Find, compare & contact
Tiopronin
API Manufacturers & Suppliers
Bangladesh
India
United States
Filters
Reset current filters
Type
Production region
Qualifications
Country of origin
Follow us
Producer
Produced in:
Established in: 2011
MOQ: 1 kg
Employees: 10+
Fast Response and Good Communication
Willingness To Start From Small
Flexible Payment Terms
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Tiopronin API 1953-02-2?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Tiopronin. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Tiopronin
- Synonyms:
- alpha-MPG , alpha-mercaptopropionylglycine , Tiopronine
- Cas Number:
- 1953-02-2
- DrugBank number:
- DB06823
- Unique Ingredient Identifier:
- C5W04GO61S
About Tiopronin
Here, you can find what Tiopronin is used for, in short. Tiopronin is a prescription thiol drug used primarily in the treatment of severe homozygous cystinuria. Patients with cystinuria excrete high levels of cystine in their urine and are at risk for kidney stone formation. Tiopronin is used as a second-line therapy to control the rate of cystine precipitation and excretion, and prevent kidney stone formation.
It is used after a failure of the non-pharmacological first line treatment consisting of increased fluid intake, restriction of sodium and protein, and urinary alkalinization. As cystinuria is a relatively rare disease, tiopronin is classified as an orphan drug and is not patented in the United States. It is similar to d-penicillamine in use and efficacy, but offers the advantage of far less adverse effects. Tiopronin is dosed on an individual basis using close monitoring of urinary cystine concentrations and urinary output.
Ask the supplier for a certificate of analysis to find out more about the quality of Tiopronin.
Tiopronin is a type of Detoxifiers in oncolytics
Detoxifiers in oncolytics are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that play a crucial role in cancer treatment. These detoxifiers are specifically designed to remove or neutralize harmful substances in the body, including carcinogens and toxins, thereby aiding in the detoxification process during oncolytic therapy.
The primary objective of detoxifiers in oncolytics is to enhance the effectiveness of cancer treatments while minimizing the side effects associated with chemotherapy and other therapies. By eliminating or reducing the presence of toxins in the body, these APIs promote the body's natural ability to fight cancer and enhance the overall treatment outcome.
Detoxifiers in oncolytics function through various mechanisms, such as enzymatic reactions, oxidation, reduction, conjugation, or binding with specific molecular targets. These mechanisms allow the detoxifiers to facilitate the breakdown or elimination of toxic substances and their metabolites from the body, ultimately reducing the toxic burden on healthy tissues and organs.
Pharmaceutical companies invest significant efforts in developing and manufacturing detoxifiers in oncolytics, ensuring their safety, efficacy, and compliance with regulatory standards. The ongoing research in this field aims to identify novel detoxifiers with improved specificity, selectivity, and reduced adverse effects. Furthermore, the combination of detoxifiers with other oncolytic agents and targeted therapies holds promising prospects in the field of cancer treatment.
In conclusion, detoxifiers in oncolytics are a vital component of cancer treatment regimens, playing a crucial role in enhancing therapeutic outcomes while minimizing the toxic effects of cancer therapies. The continuous advancements in this subcategory of pharmaceutical APIs hold great potential for improving the overall effectiveness and safety of cancer treatments.
Tiopronin (Detoxifiers in oncolytics), classified under Anticancer drugs
Anticancer drugs belong to the pharmaceutical API (Active Pharmaceutical Ingredient) category designed specifically to combat cancer cells. These powerful medications play a crucial role in cancer treatment and are developed to target and destroy cancerous cells, preventing their growth and spread.
Anticancer drugs are classified based on their mode of action and can include various types such as chemotherapy drugs, targeted therapy drugs, immunotherapy drugs, and hormonal therapy drugs. Chemotherapy drugs work by interfering with the cell division process, thereby inhibiting the growth of cancer cells. Targeted therapy drugs, on the other hand, are designed to attack specific molecules or genes involved in cancer growth, minimizing damage to healthy cells. Immunotherapy drugs stimulate the body's immune system to recognize and destroy cancer cells. Hormonal therapy drugs are used in cancers that are hormone-dependent, such as breast or prostate cancer, to block the hormones that fuel cancer cell growth.
These APIs are typically synthesized through complex chemical processes in state-of-the-art manufacturing facilities. Stringent quality control measures ensure the purity, potency, and safety of these drugs. Anticancer APIs undergo rigorous testing and adhere to stringent regulatory guidelines before being approved for clinical use.
Due to their critical role in cancer treatment, anticancer drugs are in high demand worldwide. Researchers and pharmaceutical companies continually strive to develop new and more effective APIs in this category to enhance treatment outcomes and minimize side effects. The ongoing advancements in the field of anticancer drug development offer hope for improved cancer therapies and better patient outcomes.
Tiopronin manufacturers | traders | suppliers
We have 5 companies offering Tiopronin produced in 4 different countries.
Get in contact with the supplier of your choice:
- Shandong Octagon Chemicals Limited from China, product country of origin China
- Okami Chemical Industry from Japan, product country of origin Japan
- Porton Fine Chem. from China, product country of origin China
- Sanofi from France, product country of origin France
- MSN Life Sciences from India, product country of origin India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
